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Use of the QuantiFERON®-TB Gold Assay in Pregnant Patients 
 
I find the article, “Use of the QuantiFERON®-TB Gold Assay in Pregnant Patients”,1 in your 
journal very interesting. I have not read any other work done on QuantiFERON in pregnant 
woman.  In our practice, we have noticed a few pregnant women, especially in second and third 
trimester, have had “indeterminate” QuantiFERON®-TB Gold Assay results and when these 
were repeated at six-weeks postpartum, they showed a definite positive or a negative result.  Our 
feeling is the immune changes during pregnancy are significant in later half of the pregnancy 
which interferes with the QuantiFERON®-TB Gold Assay. We would be interested to know what 
was the gestation of the women enrolled by Chehab BM et al. for their study “Use of the 
QuantiFERON®-TB Gold Assay in Pregnant Patients”? 
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Response: 
 The subjects in this study were patients of the local health department.  Study data were 
collected only on pregnancy status, not gestational age.  It is very difficult to track these patients 
over time because the health department does not provide a full-range of primary care services.  
Patients are not seen regularly.  Thus, the question posed in the Letter to the Editor forms the 
basis for an interesting future study. 
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